Examination of Complementary Treatment Use of Individuals with Interstitial Cystitis: Descriptive Study

Year 2024, Volume: 19 Issue: 1, 16 - 22, 27.02.2024

Yeliz Culha Ezgi Seyhan Ak Mehmet Gokhan Culha

Abstract

Objective: The aim of this study was to examine the use of complementary therapy in individuals with interstitial cystitis.
Material and Methods: This study, which was carried out in a descriptive research design, was carried out with 80 female patients over 18 years of age with interstitial cystitis, who applied to the Urology Outpatient Clinic of a city hospital in Istanbul between January and July 2023. The data were collected by face-to-face (onsite) interview method using a form prepared by the researchers in line with the literature to determine the socio-demographic characteristics of the patients and their use of complementary therapy. Data were analyzed using SPSS 22 statistical software for Windows. Results are reported as mean ± SD. Ethics committee and institutional permission were obtained before starting the study.
Results: When the characteristics of the individuals included in the study were examined; The mean age was 42.80±10.68 years, 60% did not have a chronic disease, 65% used any complementary treatment method, 43.2% used herbal treatment method, 50% did not receive complementary treatment. 55% received this information from the physician, 50% used complementary therapy to reduce their pain, 61.5% did not experience any side effects after using complementary therapy, 80.8% believed that complementary therapy was effective. It was determined that 53.8% of them did not share the complementary treatment methods they used with the physician or nurse.
Conclusion: It was seen that the majority of individuals with interstitial cystitis used any complementary treatment, half of them did not get information before using the treatment, and more than half did not share the complementary treatment methods they used with the physician or nurse.

Keywords

Complementary medicine, complementary therapies, interstitial cystitis, painful bladder syndrome

Ethical Statement

The study was approved by Istanbul Prof. Dr. Cemil Tascıoglu Clinical Research Ethics Committee Board (approval date and number: 2023/16). Patients were informed as to the study. And their verbal and written consent was taken.

Supporting Institution

This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.

References

• Colemeadow J, Sahai A, Malde S. Clinical management of bladder pain syndrome/interstitial cystitis: a review on current recommendations and emerging treatment options. Research and Reports in Urology. 2020; 12: 331. https://doi.org/10.2147/RRU.S238746
• Mertoglu O, Budak S, Yucel C, Kısa E, Kocaoglu Z. Treatment management in interstitial cystitis/painful bladder syndrome. Journal of Gynecology-Obstetrics and Neonatology Medicine. 2018;15(2):66-9.
• Engeler DBABJ, Bananowski AP, Berghmans B, et al. EAU Guidelines. 2019;21-22.
• Kocak T, Acar O, Tarhan F, et al. Bladder pain syndrome (interstitial cystitis) consensus. Journal of Urological Surgery. 2019;7(4):251-263.
• Anger JT, Dallas KB., Bresee C, De Hoedt AM., Barbour KE., Hoggatt K., ... & Freedland, SJ. National prevalence of IC/BPS in women and men utilizing veterans health administration data. Frontiers in Pain Research. 2022;3:925834.
• Griffith J. Designing a mobile health application prototype for the management of interstitial cystitis/painful bladder syndrome. Precision Healthcare through Informatics IOS Press; 2017.p.94-97. https://doi.org/10.3233/978-1-61499-830-3-94
• Hanno PM, Erickson D, Moldwin R, Faraday MM. American Urological Association. Diagnosis and treatment of interstitial cystitis/bladder pain syndrome: AUA guideline amendment. J Urol.2015;193:1545-53.
• Forrest JB, Dell JR. Successful management of interstitial cystitis in clinical practice. Urology. 2007; (Suppl 4A):82-86. https://doi.org/10.1016/j.urology.2006.08.1110
• Kurt H, Keskek SÖ, Cil T, Canataroglu A. Complementary/alternative therapy use in patients with breast cancer. Turkish Journal of Oncology. 2013;28(1):10-15. https://doi.org/10.5505/tjoncol.2013.827
• Ozturk YE, Dombekci HA, Unal S. Use of traditional complementary and alternative medicine. Journal of Complementary and Anatolian Medicine. 2020;1(3):23-35. National Center for Complementary and Integrative Health. [Accessed 01.12.2022] Access link: http://nccam.nih.gov/health/whatiscam).
• Unal M, Dagdeviren HN. Traditional and complementary medicine methods. Eurasian Journal of Family Medicine. 2019;8(1):1-9. https://doi.org/10.33880/ejfm.2019080101
• Guven SD, Muz, G, Erturk NE, Ozcan, A. Use of complementary and alternative treatment in the patients with hypertension. Balikesir Journal of Health Sciences. 2013;2(3).
• Tangkiatkumjai M, Boardman H, Walker DM. Potential factors that influence usage of complementary and alternative medicine worldwide: a systematic review. BMC Complement Med Ther. 2020;20(1):363. https://doi.org/10.1186/s12906-020-03157-2
• Ucar A, Canbolat O. Complementary and alternative treatment utilization in cardiovascular diseases. Turk J Cardiovasc Nurs. 2021;12(29):155-162. https://doi.org/10.5543/khd.2021.21-20-29
• Solmaz T, Altay B. University students’ use of complementary and alternative treatment methods. Pamukkale Medical Journal. 2019; 12:387-393. https://doi.org/10.31362/patd.526867
• Karakoc MD. Oncology patients’ use of complementary and alternative treatment methods. Pamukkale Medical Journal. 2020;13(1):69-80.
• Nural N, Cakmak S. The use of complementary and alternative therapies by individuals with chronic diseases. Journal of Traditional Medical Complementary Therapies. 2018;1(1):1-9.
• Hasan SS, Ahmed SI, Bukhari, NI, Loon WCW. Use of complementary and alternative medicine among patients with chronic diseases at outpatient clinics. Complementary Therapies in Clinical Practice. 2009;15(3):152-157. https://doi.org/10.1016/j.ctcp.2009.02.003
• Jia X, Crouss T, Rana N, Whitmore KE. Complementary and alternative medicine for the management of interstitial cystitis/bladder pain syndrome: a recent update. Current Bladder Dysfunction Reports. 2020;15:214-218. https://doi.org/10.1007/s11884-020-00594-0
• Hung HH, Chen WC, Chen YH, Chiu LT, Chen HY. Evaluation of the efficacy of Chinese herbal medicine and acupuncture for the prevention of mental disorders in interstitial cystitis patients: A nationwide population-based study. Medicine. 2020;99(30):e21422. https://doi.org/10.1097/MD.0000000000021422
• Atchley MD., Shah NM, Whitmore KE. Complementary and alternative medical therapies for interstitial cystitis: an update from the United States. Translational Andrology and Urology.2015;4(6): 662.
• Leong FC. Complementary and alternative medications for chronic pelvic pain. Obstet Gynecol Clin North Am. 2014;41(3):503-10.
• Oha-oka H. Clinical efcacy of 1-year intensive systematic dietary manipulation as complementary and alternative medicine therapies on female patients with interstitial cystitis/bladder pain syndrome. Urol. 2017;106:50-4.
• Kanter G, Komesu Y, Qaedan F, Rogers R. Mindfulness-based stress reduction as a novel treatment for interstitial cystitis/bladder pain syndrome: a randomized controlled trial. Am J Obstet Gynecol. 2016. https://doi.org/10.1016/j.ajog.2016.01.014
• Bouchard B, Campeau, L. Quality, value, and efficacy of complementary and alternative medicine in the treatment of interstitial cystitis/bladder pain syndrome. Current Bladder Dysfunction Reports. 2023;18(1):51-58.
• Verghese TS, Riordain RN, Champaneria R, Latthe PM. Complementary therapies for bladder pain syndrome: a systematic review. International Urogynecology Journal. 2016;27:1127-1136. https://doi.org/10.1007/s00192-015-2886-3
• Manya K, Champion B, Dunning T. The use of complementary and alternative medicine among people living with diabetes in Sydney. BMC Complementary and Alternative Medicine. 2012;12:1-5. https://doi.org/10.1186/1472-6882-12-2